Synergism between the phosphatidylinositol 3-kinase p110β isoform inhibitor AZD6482 and the mixed lineage kinase 3 inhibitor URMC-099 on the blockade of glioblastoma cell motility...

por Zhao, Hua-fu, Wu, Chang-peng, Zhou, Xiu-ming, Diao, Peng-yu, Xu, Yan-wen, Liu, Jing, Wang, Jing, Huang, Xian-jian, Liu, Wen-lan, Chen, Zhong-ping, Huang, Guo-dong, Li, Wei-ping
Publicado 2021

Correction to: Synergism between the phosphatidylinositol 3-kinase p110β isoform inhibitor AZD6482 and the mixed lineage kinase 3 inhibitor URMC-099 on the blockade of glioblastoma...

por Zhao, Hua‑fu, Wu, Chang‑peng, Zhou, Xiu‑ming, Diao, Peng‑yu, Xu, Yan‑wen, Liu, Jing, Wang, Jing, Huang, Xian‑jian, Liu, Wen‑lan, Chen, Zhong‑ping, Huang, Guo‑dong, Li, Wei‑ping
Publicado 2021

Identification of prognostic values defined by copy number variation, mRNA and protein expression of LANCL2 and EGFR in glioblastoma patients

por Zhao, Hua-fu, Zhou, Xiu-ming, Wang, Jing, Chen, Fan-fan, Wu, Chang-peng, Diao, Peng-yu, Cai, Lin-rong, Chen, Lei, Xu, Yan-wen, Liu, Jing, Li, Zong-yang, Liu, Wen-lan, Chen, Zhong-ping, Huang, Guo-dong, Li, Wei-ping
Publicado 2021